PDKnowledge Guide
Boehringer Ingelheim
  • Home
  • Understanding PD
    • Definition of PD
    • Prevalence of PD
    • Impact on quality of life
    • Pathophysiology of PD
    • Clinical presentation
    • Motor symptoms of PD
    • Non-motor symptoms of PD
    • Diagnosis of PD
    • Scales and scores for assessing PD symptoms
    • Pharmacological treatment options for PD
      • Pharmacological treatment options
      • Dopaminergic agents
      • Treatment decision pathway
    • Visual library
  • Mirapexin®/Sifrol® (pramipexole)
    • General introduction
    • Mechanism of action
    • Clinical evidence
      • Motor symptoms
      • Non-motor symptoms
      • Ongoing research
  • References
  • Congresses & media events
    • International congress schedule
    • Media events
  • Glossary
  • Contact

Sitemap

Sitemap

  • Home
  • Understanding PD
    • Definition of PD
    • Prevalence of PD
    • Impact on quality of life
    • Pathophisiology of PD
    • Clinical presentation
    • Motor symptoms of PD
    • Non-motor symptoms of PD
    • Diagnosis of PD
    • Scales and scores for assessing PD symptoms
    • Pharmacological treatment options for PD
      • Pharmacological treatment options
      • Dopaminergic agents
      • Treatment decision pathway
    • Visual library
  • Mirapexin® / Sifrol® (pramipexole)
    • General introduction
    • Mechanism of action
    • Clinical evidence
      • Motor symptoms
      • Non-motor symptoms
      • Ongoing research
  • References
  • Congresses & media events
    • International congress schedule
    • Media events
  • Glossary
  • About Boehringer Ingelheim
  • Terms of use
  • Imprint
  • Contact
 
Home | Understanding PD | Mirapexin®/Sifrol® (pramipexole) | References | Congresses & media events | Glossary
About Boehringer Ingelheim | Terms of use | Imprint | Contact | Sitemap
© 2009 Boehringer Ingelheim GmbH. All rights reserved. Last updated: October 2009